Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Sleep disorders stories

Oct 29, 2026

Study finds one in four users discontinue insomnia drug lemborexant due to side effects

Researchers from Rutgers and other universities analyzed hundreds of online reviews of lemborexant, a prescription insomnia medication, and found that approximately 25% of reviewers stopped or planned to stop taking the drug due to troubling side effects.

Oct 29, 2026·2 sources
00
Aug 5, 2026

FDA approves Takeda's Orzeyful, first orexin agonist drug for narcolepsy type 1

The FDA has approved Takeda's Orzeyful (orexin agonist) for treating narcolepsy type 1 in adults, marking the first approval in a new class of sleep medicines that addresses the full range of narcolepsy symptoms. The approval is expected to reshape the treatment paradigm and launch a closely watched commercial drug race.

Aug 5, 2026·5 sources
00
Apr 21, 2026

Frequent Daytime Napping Linked to Early Signs of Health Decline in Older Adults

Frequent, long, or early-day naps in older adults are linked to higher mortality risk and may signal underlying conditions like cardiovascular disease, neurodegeneration, or sleep disorders, suggesting daytime sleep patterns could serve as an early warning sign of declining health.

Apr 21, 2026·4 sources
00

Top claims

  • ▪Nearly one-third of online reviewers analyzing lemborexant described experiencing vivid dreams or nightmares while taking the insomnia drug.
  • ▪A study by researchers from Rutgers, Virginia Commonwealth University, and the University of Sydney found that 70 out of 260 online reviewers (about 1 in 4) stopped or planned to stop taking the insomnia drug lemborexant.
  • ▪Study lead author Abanoub J. Armanious stated that clinical trials track side effect frequency but are less equipped to measure how much a side effect impacts a patient's decision to discontinue treatment.

Subtopics

Drug Approval and Clinical Trials2Drug Policy, Pricing & Approval2Sleep & circadian rhythm2Age related cognitive decline1Biomarkers & bloodwork testing1Cardiovascular aging experts1Cardiovascular diseases1Clinical trials1Drug development1Drug safety1Insomnia1Lifestyle, Wellness and Nutrition1Longevity & aging1Medication adherence1Neurodegeneration1Patient experience1Pharma1Preventive medicine1Recovery & Sleep1Sleep1Sleep medications1Sleep optimization1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories